An innovative cardiovascular start-up, HDAX Therapeutics, is the latest company to win $250,000 in funding following another year of the Ted Rogers Centre for Heart Research’s Entrepreneurship for Cardiovascular Health Opportunities (ECHO) program. The ECHO program...
Calculating the best ED decisions for acute heart failure patients
These new online tools may reduce HF hospitalizations
An eye towards quality improvement
Providing the best possible care to patients and families
How hospitals can address heart failure burden
Dr. Adrian Hernandez: blend systems of care with systems of research
A Canadian first for new implantable technology
Latest advances in mechanical circulatory support